20 results
8-K
BGLC
BioNexus Gene Lab Corp
9 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:37pm
Department of the Nasdaq Stock Market (“Nasdaq”) regarding the Company’s failure to comply with Nasdaq Continued Listing Rule (“Rule”) 5550(a)(2), which
DEF 14C
BGLC
BioNexus Gene Lab Corp
29 Feb 24
Information statement
5:16pm
personnel. Questions about compliance should be addressed to the Legal Department.
4.3 No director, officer or employee may purchase or sell any Company
PRE 14C
BGLC
BioNexus Gene Lab Corp
26 Jan 24
Preliminary information
4:05pm
personnel. Questions about compliance should be addressed to the Legal Department.
4.3 No director, officer or employee may purchase or sell any
8-K
z4qrrrpn7nm
13 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:40pm
8-K
EX-1.1
gpu9o
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
424B4
rx0z0b203dcz1u3n4 ay
21 Jul 23
Prospectus supplement with pricing info
3:37pm
10-K
c9ipwgdfkt2c0l1nju7r
31 Mar 20
Annual report
1:12pm
S-1/A
3vfzro4
25 Feb 19
IPO registration (amended)
3:30pm
S-1
pd0bm9yivyb0phcxjm3m
29 Jan 19
IPO registration
12:00am
- Prev
- 1
- Next